Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $987.25, with a market capitalization of 933.33B. The stock trades at a price-to-earnings (P/E) ratio of 49.34 and offers a dividend yield of 60.1%.
As of 2025-12-10, Eli Lilly(LLY) stock has fluctuated between $977.12 and $988.50. The current price stands at $987.25, placing the stock +1.0% above today's low and -0.1% off the high.
Eli Lilly(LLY) shares are trading with a volume of 356.68K, against a daily average of 3.18M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Eli Lilly and Co. (NYSE: LLY) on Tuesday today announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The synth...
HSBC raised the firm’s price target on Eli Lilly (LLY) to $1,070 from $850 and keeps a Hold rating on the shares as part of a 2026 outlook for the pharma group....
(RTTNews) - Eli Lilly and Company (LLY) announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. This next-generat...
Analyst ratings
74%
of 31 ratingsMore LLY News
Eli Lilly will make small molecular synthetic and peptide medicines at the Huntsville plant. Mike Blake/Reuters Eli Lilly LLY -1.60 %decrease; red down pointin...
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion...
Key Points This company is a leader in a market that may approach $100 billion in a few years. This player’s key products are delivering billion-dollar revenu...
Nobel Prize-winning chemist Carolyn Bertozzi has rejoined Eli Lilly’s (LLY) board of directors, the pharmaceutical company has announced. TipRanks Cyber Monday...
(RTTNews) - Eli Lilly and Company (LLY) on Tuesday said its tender offer to acquire Adverum Biotechnologies expired on December 8, 2025, with 16.49 million shar...
Eli Lilly (LLY) announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca – pirtobrutinib -, a non-covalent Bruton tyrosine kinase, or BTK, in...
Biotech Structure Therapeutics’ (GPCR) shares rallied 102.49% on Monday after mid-stage data for its obesity pill topped competing offerings from Eli Lilly (LLY...